YD Bio (NASDAQ:YDES) Shares Gap Up – What’s Next?

YD Bio Limited (NASDAQ:YDES) gapped up prior to trading on Monday . The stock had previously closed at $7.43, but opened at $7.79. YD Bio shares last traded at $7.41, with a volume of 5,606 shares changing hands.

Wall Street Analysts Forecast Growth

YDES has been the topic of several research reports. Wall Street Zen raised shares of YD Bio from a “sell” rating to a “hold” rating in a research report on Saturday, February 28th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of YD Bio in a research note on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Sell”.

YD Bio Price Performance

The stock’s 50-day moving average price is $8.64.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in YD Bio stock. Geode Capital Management LLC raised its position in YD Bio Limited (NASDAQ:YDES) by 10.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 58,363 shares of the biotechnology company’s stock after purchasing an additional 5,292 shares during the period. Geode Capital Management LLC owned 0.08% of YD Bio worth $711,000 as of its most recent filing with the Securities and Exchange Commission.

About YD Bio

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.